Article
A new bioinformatics tool to help assess the significance of BRCA1 variants.
Human genomics - 11 Jul 2018
Cusin Isabelle, Teixeira Daniel, Zahn-Zabal Monique, Rech de Laval Valentine, Gleizes Anne, Viassolo Valeria, Chappuis Pierre O, Hutter Pierre, Bairoch Amos, Gaudet Pascale
Abstract excerpt
BACKGROUND: Germline pathogenic variants in the breast cancer type 1 susceptibility gene BRCA1 are associated with a 60% lifetime risk for breast and ovarian cancer. This overall risk estimate is for all BRCA1 variants; obviously, not all variants confer the same risk of developing a disease. In cancer patients, loss of BRCA1 function in tumor tissue has been associated with an increased sensitivity to platinum...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
